Demyelinating and nondemyelinating strains of mouse hepatitis virus differ in their neural cell tropism

Journal of Virology

Volumn 82, Issue 11, 2008, Pages 5519-5526

  Das Sarma, Jayasri ^a   Iacono, Kathryn ^b,d   Gard, Lilli ^b,e   Marek, Ryan ^a   Kenyon, Lawrence C ^a   Koval, Michael ^c   Weiss, Susan R ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LLC   (United States)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL GROWTH; CELL TYPE; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORRELATIONAL STUDY; DEMYELINATION; GLIA CELL; GRAY MATTER; INFECTION; MALE; MURINE HEPATITIS CORONAVIRUS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS STRAIN; WHITE MATTER;

ANIMALS; ANTIGENS, VIRAL; CORONAVIRUS INFECTIONS; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; MURINE HEPATITIS VIRUS; MYELIN SHEATH; NERVOUS SYSTEM DISEASES; SPINAL CORD; TROPISM;

MURINE HEPATITIS VIRUS; MUS;

EID: 43949097556     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01488-07     Document Type: Article

References (45)

1. Allen, I., and B. Brankin. 1993. Pathogenesis of multiple sclerosis - the immune diathesis and the role of viruses. J. Neuropathol. Exp. Neurol. 52:95-105.
2. Buchmeier, M. J., and T. E. Lane. 1999. Viral-induced neurodegenerative disease. Curr. Opin. Microbiol. 2:398-402.
3. Das Sarma, J., L. Fu, S. T. Hingley, M. M. Lai, and E. Lavi. 2001. Sequence analysis of the S gene of recombinant MHV-2/A59 coronaviruses reveals three candidate mutations associated with demyelination and hepatitis. J. Neurovirol. 7:432-436.
4. Das Sarma, J., L. Fu, J. C. Tsai, S. R. Weiss, and E. Lavi. 2000. Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus. J. Virol. 74:9106-9213.
5. De Camilli, P., P. E. Miller, F. Navone, W. E. Theurkauf, and R. B. Vallee. 1984. Distribution of microtubule-associated protein 2 in the nervous system of the rat studied by immunofluorescence. Neuroscience 11:817-846.
6. Enquist, L. W., P. J. Husak, B. W. Banfield, and G. A. Smith. 1998. Infection and spread of alphaherpesviruses in the nervous system. Adv. Virus Res. 51:237-347.
7. Enquist, L. W., M. J. Tomishima, S. Gross, and G. A. Smith. 2002. Directional spread of an alpha-herpesvirus in the nervous system. Vet. Microbiol. 86:5-16.
8. Fazakerley, J. K., and M. J. Buchmeier. 1993. Pathogenesis of virus-induced demyelination. Adv. Virus Res. 42:249-324.
9. Fleming, J. O., M. D. Trousdale, F. A. el-Zaatari, S. A. Stohlman, and L. P. Weiner. 1986. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol. 58:869-875.
10. Geisert, E. E., Jr., H. G. Johnson, and L. I. Binder. 1990. Expression of microtubule-associated protein 2 by reactive astrocytes. Proc. Natl. Acad. Sci. USA 87:3967-3971.
11. Haspel, M. V., P. W. Lampert, and M. B. Oldstone. 1978. Temperature-sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination. Proc. Natl. Acad. Sci. USA 75:4033-4036.
12. Houtman, J. J., and J. O. Fleming. 1996. Pathogenesis of mouse hepatitis virus-induced demyelination. J. Neurovirol 2:361-376.
13. Kalicharran, K., and S. Dales. 1996. The murine coronavirus as a model of trafficking and assembly of viral proteins in neural tissue. Trends Microbiol. 4:264-269.
14. Kalicharran, K., D. Mohandas, G. Wilson, and S. Dales. 1996. Regulation of the initiation of coronavirus JHM infection in primary oligodendrocytes and L-2 fibroblasts. Virology 225:33-43.
15. Knobler, R. L., M. Dubois-Dalcq, M. V. Haspel, A. P. Claysmith, P. W. Lampert, and M. B. Oldstone. 1981. Selective localization of wild type and mutant mouse hepatitis virus (JHM strain) antigens in CNS tissue by fluorescence, light and electron microscopy. J. Neuroimmunol. 1:81-92.
16. Knobler, R. L., M. V. Haspel, and M. B. Oldstone. 1981. Mouse hepatitis virus type 4 (JHM strains)-induced fatal central nervous system disease. I. Genetic control and murine neuron as the susceptible site of disease. J. Exp. Med. 153:832-843.
17. Knobler, R. L., P. W. Lampert, and M. B. Oldstone. 1982. Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4. Nature 298:279-280.
18. Koyanagi, Y., S. Miles, R. T. Mitsuyasu, J. E. Merrill, H. V. Vinters, and I. S. Chen. 1987. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819-822.
19. Lavi, E., P. S. Fishman, M. K. Highkin, and S. R. Weiss. 1988. Limbic encephalitis after inhalation of a murine coronavirus. Lab. Investig. 58:31-36.
20. Lavi, E., D. H. Gilden, M. K. Highkin, and S. R. Weiss. 1984. Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. J. Virol. 51:563-566.
21. Lavi, E., D. H. Gilden, Z. Wroblewska, L. B. Rorke, and S. R. Weiss. 1984. Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology 34:597-603.
22. Lavi, E., A. Suzumura, M. Hirayama, M. K. Highkin, D. M. Dambach, D. H. Silberberg, and S. R. Weiss. 1987. Coronavirus mouse hepatitis virus (MHV)-A59 causes a persistent, productive infection in primary glial cell cultures. Microb. Pathog. 3:79-86.
23. + T cells prevent murine coronavirus spread to the spinal cord and subsequent demyelination. J. Virol. 79:3370-3381.
24. Major, E. O., K. Amemiya, C. S. Tornatore, S. A. Houff, and J. R. Berger. 1992. Pathogenesis and molecular biology of progressive multifocal leukoen-cephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin. Microbiol. Rev. 5:49-73.
25. McFarlin, D. E., and H. F. McFarland. 1982. Multiple sclerosis (first of two parts). N. Engl. J. Med. 307:1183-1188.
26. McFarlin, D. E., and H. F. McFarland. 1982. Multiple sclerosis (second of two parts). N. Engl. J. Med. 307:1246-1251.
27. Moskophidis, D., M. Battegay, M. van den Broek, E. Laine, U. Huffmann-Rohrer, and R. M. Zinkernagel. 1995. Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus. J. Gen. Virol. 76:381-391.
28. Navas, S., S. H. Seo, M. M. Chua, J. D. Sarma, E. Lavi, S. T. Hingley, and S. R. Weiss. 2001. Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis. J. Virol. 75:2452-2457.
29. Perlman, S., G. Jacobsen, A. L. Olson, and A. Afifi. 1990. Identification of the spinal cord as a major site of persistence during chronic infection with a murine coronavirus. Virology 175:418-426.
30. Perlman, S., N. Sun, and E. M. Barnett. 1995. Spread of MHV-JHM from nasal cavity to white matter of spinal cord. Transneuronal movement and involvement of astrocytes. Adv. Exp. Med. Biol. 380:73-78.
31. Phillips, J. J., M. M. Chua, E. Lavi, and S. R. Weiss. 1999. Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence. J. Virol. 73:7752-7760.
32. Phillips, J. J., M. M. Chua, G. F. Rall, and S. R. Weiss. 2002. Murine coronavirus spike glycoprotein mediates degree of viral spread, inflammation, and virus-induced immunopathology in the central nervous system. Virology 301:109-120.
33. Qiu, Z., S. T. Hingley, G. Simmons, C. Yu, J. Das Sarma, P. Bates, and S. R. Weiss. 2006. Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry. J. Virol. 80:5768-5776.
34. Reed, L., and H. Muench. 1938. A simple method of estimating fifty percent end points. Am. J. Hyg. 27:493-497.
35. Richardson-Burns, S. M., B. K. Kleinschmidt-DeMasters, R. L. DeBiasi, and K. L. Tyler. 2002. Progressive multifocal leukoencephalopathy and apoptosis of infected oligodendrocytes in the central nervous system of patients with and without AIDS. Arch. Neurol. 59:1930-1936.
36. Riederer, B. M., E. Draberova, V. Viklicky, and P. Draber. 1995. Changes of MAP2 phosphorylation during brain development. J. Histochem. Cytochem. 43:1269-1284.
37. Roussarie, J. P., C. Ruffle, J. M. Edgar, I. Griffiths, and M. Brahic. 2007. Axon myelin transfer of a non-enveloped virus. PLoS One 2:e1331.
38. Sarma, J. D., E. Scheen, S. H. Seo, M. Koval, and S. R. Weiss, 2002. Enhanced green fluorescent protein expression may be used to monitor murine coronavirus spread in vitro and in the mouse central nervous system. J. Neurovirol 8:381-391.
39. Stohlman, S. A., and L. P. Weiner. 1981. Chronic central nervous system demyelination in mice after JHM virus infection. Neurology 31:38-44.
40. Tardieu, M., O. Boespflug, and T. Barbe. 1986. Selective tropism of a neurotropic coronavirus for ependymal cells, neurons, and meningeal cells. J. Virol. 60:574-582.
41. Weiner, H. L., M. L. Powers, and B. N. Fields. 1980. Absolute linkage of virulence and central nervous system cell tropism of reoviruses to viral hemagglutinin. J. Infect. Dis. 141:609-616.
42. Weiner, L. P. 1973. Pathogenesis of demyelination induced by a mouse hepatitis. Arch. Neurol. 28:298-303.
43. Weiner, L. P., R. T. Johnson, and R. M. Herndon. 1973. Viral infections and demyelinating diseases. N. Engl. J. Med. 288:1103-1110.
44. Wodarz, D., and D. C. Krakauer. 2000. Defining CTL-induced pathology: implications for HIV. Virology 274:94-104.
45. Zoecklein, L. J., K. D. Pavelko, J. Gamez, L. Papke, D. B. McGavern, D. R. Ure, M. K. Njenga, A. J. Johnson, S. Nakane, and M. Rodriguez. 2003. Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus. Brain Pathol. 13:291-308.